Clinical Trials Directory

Trials / Unknown

UnknownNCT06215001

Individualized Selection of PEEP in Patients Affected by Expiratory Flow Limitation

Individualized Selection of PEEP in Patients Affected by Expiratory Flow Limitation: a Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,536 (estimated)
Sponsor
Università degli Studi di Ferrara · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to compare different mechanical ventilation settings in Patients undergoing laparoscopic surgery and affected by Expiratory flow limitation. The main question\[s\] it aims to answer are: * If individualizing mechanical ventilation on expiratory flow limitation can reduce pulmonary postoperative complications; * If patients with expiratory flow limitation have a higher incidence of pulmonary postoperative complications as compared to patients with no expiratory flow limitation; Participants will be screened for expiratory fow limitation and patients with positive screening will be randomized into two groups. Each group will receive a different intraoperative mechanical ventilation: * Personalized positive end-expiratory pressure based on EFL * Standard of care positive end-expiratory pressure Researchers will then compare the two groups to see if the incidence of pulmonary postoperative complications in the first 7 days after surgery is different.

Conditions

Interventions

TypeNameDescription
PROCEDUREMechanical ventilation setting (Positive end-expiratory pressure) according to Expiratory Flow LimitationPositive End expiratory pressure will be set according to the positive end-expiratory pressure able to revert the expiratory flow limitation.
PROCEDUREMechanical ventilation setting (Positive end-expiratory pressure) not according to Expiratory Flow LimitationPositive End expiratory pressure will be set not according to the positive end-expiratory pressure able to revert the expiratory flow limitation but to a standard level of 4 cmH2O.

Timeline

Start date
2024-02-01
Primary completion
2024-12-31
Completion
2025-03-01
First posted
2024-01-22
Last updated
2024-01-22

Source: ClinicalTrials.gov record NCT06215001. Inclusion in this directory is not an endorsement.